As an increased body of COVID-19 related research is now available, it becomes
apparent that the effects of COVID-19 extend beyond that of the respiratory
system. Among others, the endocrine system is particularly vulnerable to
perturbation from the COVID-19 infection. The present scoping review summarizes
the bidirectional relationship between COVID-19 and endocrine system in children
and adolescents, by describing both the possible susceptibility of children and
adolescents without endocrinopathies to endocrine disorders following COVID-19
infection, but also the potential susceptibility to COVID-19 infection and
severe infection, or the aggravation of endocrine dysfunction in patients with
pre-existing endocrine diseases. Data suggest increased obesity and diabetes
rates, as well as increased severity and frequency of diabetic ketoacidosis
following COVID-19 infection. Conversely, patients with diabetes and obesity may
experience a more severe course of COVID-19 infection. However, in the majority
of cases, children and adolescents with well-managed and regulated endocrine
disorders do not appear to be at increased risk of infection or severe infection
from COVID-19. Thus, adhering to the appropriate “sick day management
rules”, maintaining adequate supply of medications and supplies, keeping
close contact with the therapeutic team and seeking medical help without delay
when needed, are the main recommendations for a safe outcome. Additional lessons
learnt during the pandemic include the risk for mental health diseases caused by
children’s disrupted routine due to COVID-19 related protective measures
and the importance of adopting alternative communication options, such as
telehealth visits, in order to ensure uninterrupted endocrine care.